Biogen Inc. (BIIB) Stock Overview
Explore Biogen Inc.’s financial performance, market position, analyst ratings, and future outlook.
Biogen Inc. (BIIB)
Key Financials
Key Financials
Market Cap
30B
P/E Ratio
21.47
EPS (TTM)
$15.84
ROE
0.08%
BIIB Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Biogen Inc. (BIIB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 50.59, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $137.98.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 21.47 and a market capitalization of 30B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.